missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human SF3B14 (aa 64-124) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (100%), Rat (100%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-57077 (PA5-57077. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
SF3B14 encodes a 14 kDa protein subunit of the splicing factor 3b complex. Splicing factor 3b associates with both the U2 and U11/U12 small nuclear ribonucleoprotein complexes (U2 snRNP) of spliceosomes. This 14 kDa protein interacts directly with subunit 1 of the splicing factor 3b complex. This 14 kDa protein also interacts directly with the adenosine that carries out the first transesterification step of splicing at the pre-mRNA branch site.
Specifications
Specifications
| Accession Number | Q9Y3B4 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 51639 |
| Name | Human SF3B14 (aa 64-124) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 0610009D07Rik; 6030419K15Rik; AV001342; CGI-110; HSPC175; Ht006; P14; pre mRNA branch site protein p14; pre-mRNA branch site protein p14; SAP14; SAP14a; SF3b 14 kDa subunit; Sf3b14; SF3B14a; SF3B6; spliceosome-associated protein, 14 kDa subunit; spliceosome-associated protein, 14-kDa; Splicing factor 3 B subunit 6; splicing factor 3 B, 14 kDa subunit; splicing factor 3 B, 14 kDa subunit-like; splicing factor 3 B, subunit 6; splicing factor 3 b, subunit 6, 14 kDa |
| Common Name | SF3B14 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction